EMD SERONO, INC. for EMD SERONO INC
What was lobbied
13 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
H.R. 133: Consolidated Appropriations Act, 2021; provisions related to funding for COVID-19 vaccine and testing
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
Trade (domestic/foreign) TRD
General discussions related to Sec. 301 Tariffs
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
Science/Technology SCI
H.R. 7178: Creating Helpful Incentives to Produce Semiconductors (CHIPS) for America Act; provisions related to semiconductor manufacturing S.3933: Creating Helpful Incentives to Produce Semiconductors (CHIPS) for America Act; provisions related to semiconductor manufacturing
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
Defense DEF
S. 4049: National Defense Authorization Act for Fiscal Year 2021; provisions related to the Creating Helpful Incentives to Produce Semiconductors (CHIPS) for America Act portions of bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
Chemicals/Chemical Industry CHM
General discussions related to the Toxic Substances Control Act; provisions related to Section 5/Pre-Manufacture Notice (PMN) General discussions related to National raw materials stockpile for future vaccine preparedness
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
Budget/Appropriations BUD
H.R. 133: Consolidated Appropriations Act, 2021; provisions related to funding for closing the "Homework Gap"
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
Taxation/Internal Revenue Code TAX
H.R. 6930: Manufacturing API, Drugs, and Excipients (MADE) in America Act of 2020; issues related to tax incentives for reshoring of U.S. supply chains H.R. 7178: Creating Helpful Incentives to Produce Semiconductors (CHIPS) for America Act; issues related to tax incentives for reshoring of U.S. supply chains S.3933: Creating Helpful Incentives to Produce Semiconductors (CHIPS) for America Act;issues related to tax incentives for reshoring of U.S. supply chains S.3945: Bring Entrepreneurial Advancements To Consumers Here In North America Act; issues related to tax incentives for reshoring of supply chains (semiconductors and pharmaceuticals) General discussions related to the implementation of the Tax Cut and Jobs Act of 2017 (P.L. 116-97)
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
| DANIEL M. HARDER | — |
| MALLORI ANNE MERANDINO | — |
| WENDY SUSSMAN | — |
Copyright/Patent/Trademark CPT
General discussions regarding biopharmaceutical innovation and patent policy issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL M. HARDER | — |
| MALLORI ANNE MERANDINO | — |
| WENDY SUSSMAN | — |
Economics/Economic Development ECN
General discussion of issues related to caregiving and the Healthy Women, Healthy Economies initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL M. HARDER | — |
| MALLORI ANNE MERANDINO | — |
| WENDY SUSSMAN | — |
Health Issues HCR
H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions of the bill H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act: issues related to drug pricing Centers for Medicare & Medicaid Services (CMS-5528-ANPRM)-Advance Notice of Proposed Rulemaking (ANPRM)-Medicare Program; International Price Index Model for Medicare Part B drugs 2021 Notice of Benefit and Payment Parameters Proposed Rule - 340B Drug Pricing Program policy issues (Draft) 21st Century Cures Act 2.0; all healthcare provisions of the draft General discussions regarding support for, and importance of, care-giving General healthcare issues surrounding the COVID-19 pandemic General issues surrounding healthcare supply chain General discussions regarding drug cost and pricing policy issues General discussions regarding Most Favored Nations/International Price Index Model for Medicare Part D drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL M. HARDER | — |
| MALLORI ANNE MERANDINO | — |
| WENDY SUSSMAN | — |
Medicare/Medicaid MMM
H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions of the bill H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act: issues related to drug pricing 2021 Notice of Benefit and Payment Parameters Proposed Rule General healthcare issues surrounding the COVID-19 pandemic
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL M. HARDER | — |
| MALLORI ANNE MERANDINO | — |
| WENDY SUSSMAN | — |
Government Issues GOV
H.R.1: For the People Act of 2019; provisions related to the Foreign Agents Registration Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
Pharmacy PHA
H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions of the bill H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act: issues related to drug pricing 2021 Notice of Benefit and Payment Parameters Proposed Rule General healthcare issues surrounding the COVID-19 pandemic General issues surrounding healthcare supply chain
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL M. HARDER | — |
| MALLORI ANNE MERANDINO | — |
| WENDY SUSSMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.